Body

As well as allowing us to communicate with other people, languages are the tool we use to convey our thoughts, identity, knowledge, and the way we see and understand the world. Mastering more than one language enriches us, provides a gateway to other cultures and, according to a team of researchers led by scientists from the Universitat Oberta de Catalunya (UOC) and Pompeu Fabra University (UPF), actively using them also brings us neurological benefits and protects us from cognitive impairment associated with ageing.

DALLAS - Sept. 17, 2020 - When used to manage infections, the drug itraconazole is generally given at a single, fixed dose to all patients. But determining the correct dosage of the drug to help treat cancer isn't that simple, new research by UT Southwestern suggests.

A study conducted by Hiroshima University researchers found that using Ultraviolet C light with a wavelength of 222 nanometers which is safer to use around humans effectively kills SARS-CoV-2 -- the first research in the world to prove its efficacy against the virus that causes COVID-19.

Other studies involving 222 nm UVC, also known as Far-UVC, have so far only looked at its potency in eradicating seasonal coronaviruses that are structurally similar to the SARS-CoV-2 but not on the COVID-19-causing virus itself. A nanometer is equivalent to one billionth of a meter.

Up to one in four Danes has an unhealthy accumulation of fat in the liver, also known as fatty liver. Fatty liver is rarely the cause of symptoms in itself, but people with fatty liver have an increased risk of developing diabetes. Exactly how the two diseases are linked has, however, so far been unknown.

Women with a longer reproductive period had an elevated risk for dementia in old age, compared with those who were fertile for a shorter period, a population-based study from the University of Gothenburg shows.

Since the start of the COVID-19 pandemic, scientific and medical journals have published over 100,000 studies on SARS-CoV-2. But according to data scientists who created a machine-learning tool to analyze the deluge of publications, basic lab-based studies on the microbiology of the virus, including research on its pathogenesis and mechanisms of viral transmission, are lacking. Their analysis appears September 16 in the journal Patterns.

A study of interim data from two hospitals in an early US COVID-19 hotspot, to be presented at the ESCMID Conference on Coronavirus Disease (ECCVID, held online 23-25 September), shows that race and ethnicity were not significantly associated with higher in-hospital COVID-19 mortality, and that rates of moderate, severe, and critical forms of COVID-19 were similar between racial and ethnic groups.

When it comes to metabolic health, it's not just what you eat, it's when you eat it. Studies have shown that one effective means of losing weight and tackling obesity is to reduce the number of hours in the day that you eat. Time-restricted feeding - otherwise known as intermittent fasting - has also been shown to improve health even before weight loss kicks in.

New research to be presented at the ESCMID Conference on Coronavirus Disease (ECCVID, held online from 23-25 September) shows that one quarter of hospitalised younger patients with COVID-19 aged 18-39 years developed pneumonia, underlining the danger the disease respresents to young people. The study is by Assistant Professor Hyun ah Kim, Keimyung University Dongsan Hospital, Daegu, and Dr Hyo-Lim Hong, Daegu Catholic University Medical Center, Daegu, South Korea, and colleagues.

Scientists from Sechenov University interviewed Russian healthcare experts to find out what problems impeded the development of medical tourism in the country most and what measures would help attract foreigners. The results of the work can form the basis of the state policy in this field. Details of the study were published in the journal Frontiers in Psychology.

Research being presented at the ESCMID Conference on Coronavirus Disease (ECCVID, held online from 23-25 September) shows that persistent fatigue occurs in more than half of patients recovered from COVID-19, regardless of the seriousness of their infection. The study is by Dr Liam Townsend, St James's Hospital and Trinity Translational Medicine Institute, Trinity College, Dublin, Ireland, and colleagues.

A study investigating SARS-CoV-2 infections across 16 mink farms in the Netherlands, being presented at the ESCMID Conference on Coronavirus Disease (ECCVID, held online from 23-25 September) shows that the virus likely jumped between people and mink and back, providing strong evidence that animal to human (zoonotic) transmission is possible.

A small study by Canadian veterinary science experts being presented at this ESCMID Conference on Coronavirus Disease (ECCVID, held online from 23-25 September) suggests that a substantial proportion of pet cats and dogs can be infected by SARS-CoV-2 by their owners. Furthermore, in several cases pets found to be infected had COVID-19-like respiratory symptoms at the time their owner had COVID-19.

Metformin is the first-line drug that can lower blood sugar levels in type 2 diabetes patients. One third of patients do not respond to metformin treatment and 5 per cent experience serious side effects, which is the reason many choose to stop medicating. Researchers at Lund University in Sweden have now identified biomarkers that can show in advance how the patient will respond to metformin treatment via a simple blood test.

Greenwood, SC (September 17, 2020) - Greenwood Genetic Center (GGC) researchers, in collaboration with scientists from Belgium, Spain, and Italy, have confirmed that variants in LMNB1 cause syndromic microcephaly with variable short stature, intellectual disability, and other neurological symptoms. The findings are reported in the October issue of the American Journal of Human Genetics.